Reuters Pharma Europe 2024 – Day Three
As Reuters Pharma Europe 2024 comes to a close in Barcelona, pharmaphorum remains on site to live blog the last remaining talks and insights.
Brexit is ‘driving NHS medicines shortages,’ says report
A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are bei
Sage drops dalzanemdor for Parkinson’s after trial flop
Sage Therapeutics has suffered another disappointment after deciding that it will have to drop the Parkinson’s programme for key pipeline drug dalzanemdor after it showed
Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena
When it comes to patient-facing AI in healthcare, ChatGPT, with its tendency toward hallucination, is not going to cut it.
Trials set up filing for Lilly’s tirzepatide in sleep apnoea
Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
FT US PHARMA AND BIOTECH SUMMIT
2024 is a pivotal year for the US healthcare sector.
2nd RNA Assay Development Screening Summit
This August, the 2nd RNA Assay Development & Screening Summit returns to Boston as the first and only industry dedicated event on developing sensitive, and reproducible assay and screening meth
3rd HF Drug Discovery & Development Summit
The Industry’s Only Definitive Forum for Preclinical Heart Failure Drug Development
5th Gamma Delta T Cell Therapies Summit
The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to off
PM Society Digital Awards 2024 – Open for Entries
The PM Society Digital Awards 2024 have opened for entries!